You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
New combined treatments avoided transplantation in a child with severe pulmonary hypertension
  1. M Beghetti,
  2. L Nicod,
  3. C Barazzone-Argiroffo,
  4. P C Rimensberger
  1. maurice.beghetti@hcuge.ch

https://doi.org/10.1136/hrt.2003.019794

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Therapeutic options for the management of pulmonary hypertension have been limited for many years. However, recent progresses in the understanding of its pathology have led to the introduction of new treatments that have changed its prognosis, such as the continuous infusion of prostacyclin. Several other treatments (oral, inhaled, or subcutaneous prostacyclin, phosphodiesterase inhibitors, and endothelin …

    View Full Text